Frontlight ResearchEarly access
Head and neck cancer trials in South Korea
30 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleHead and Neck Advanced Research for Multi-Omics and Optimized Immunotherapy
- Where
- Seoul
- Age
- 20 years and over
- People
- 30
- Run by
- Samsung Medical Center
See details and how to joinNCT07211139 - No phaseTaking peopleHead and Neck Cancer Omics/Integrated Precision Medicine (HOPE)
- Where
- Seoul
- Age
- 20 years and over
- People
- 350
- Run by
- Samsung Medical Center
See details and how to joinNCT07190573 - Phase 1/2Taking peopleStudy of TU2218 in Combination With KEYTRUDA®(Pembrolizumab) in Patients With Advanced Solid Tumors
- Where
- Seongnam, Seoul, Suwon
- Age
- 18 years and over
- People
- 140 worldwide
- Run by
- TiumBio Co., Ltd.
See details and how to joinNCT05784688 - Phase 1/2Taking peopleSafety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer
- Where
- Seoul
- Age
- 18 years and over
- People
- 160 worldwide
- Run by
- CJ Bioscience, Inc.
See details and how to joinNCT05877430 - Phase 1/2Taking peopleGM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors
- Where
- Goyang-si, Seoul
- Age
- 18 years and over
- People
- 125
- Run by
- GeneMedicine Co., Ltd.
See details and how to joinNCT06265025